Evidence map›Paper›PMID 31293745›Full record

ArticleChemical science2019

Development of

Javier Hernández-Gil, Marta Braga, Bethany I Harriss, Laurence S Carroll, Chee Hau Leow, Meng-Xing Tang, Eric O Aboagye, Nicholas J Long

Open access · diamondAbstract read
In one paragraph

Article in Chemical science, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 21 citations in OpenAlex.

  1. Tetrazine-Inorganic chemistry frontiers · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Tetrazine bioorthogonal chemistry derivedFrontiers in molecular biosciences · 2022
    Review
  7. Article
  8. A kit-based aluminium-[Chemical communications (Cambridge, England) · 2021
    Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Javier Hernández-GilDepartment of Chemistry , Imperial College London , UK . Email: j.hernandez-gil@imperial.ac.uk ; Email: n.long@imperial.ac.uk.ORCID 0000-0002-6177-1971
Marta BragaDepartment of Surgery & Cancer , Imperial College London , UK . Email: eric.aboagye@imperial.ac.uk.ORCID 0000-0002-2673-776X
Bethany I HarrissDepartment of Chemistry , Imperial College London , UK . Email: j.hernandez-gil@imperial.ac.uk ; Email: n.long@imperial.ac.uk.
Laurence S CarrollDepartment of Surgery & Cancer , Imperial College London , UK . Email: eric.aboagye@imperial.ac.uk.ORCID 0000-0001-8164-9474
Chee Hau LeowDepartment of Bioengineering , Imperial College London , UK.
Meng-Xing TangDepartment of Bioengineering , Imperial College London , UK.
Eric O AboagyeDepartment of Surgery & Cancer , Imperial College London , UK . Email: eric.aboagye@imperial.ac.uk.ORCID 0000-0003-2276-6771
Nicholas J LongDepartment of Chemistry , Imperial College London , UK . Email: j.hernandez-gil@imperial.ac.uk ; Email: n.long@imperial.ac.uk.ORCID 0000-0002-8298-938X
Imperial College London · GB

Funding

Cancer Research UK 22353
6 · The paper itself

Abstract

Microbubble (MB) contrast agents have revolutionalised the way ultrasound (US) imaging can be used clinically and pre-clinically. Contrast-enhanced US offers improvements in soft-tissue contrast, as well as the ability to visualise disease processes at the molecular level. However, its inability to provide

Identifiers

PMID31293745
PMCPMC6552490
OpenAlexW2942930726

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.